BioArctic develops new treatment for Gaucher's disease

Corporate Breaking News

Home : BioArctic develops new treatment for Gaucher's disease

Nov 08 2022	BioArctic develops new treatment for Gaucher's disease
STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today announced that the company has initiated a new project focused on enzyme replacement therapy for Gaucher's disease in combination with the company's Brain Transporter technology. Today there is no...


Source:https://www.prnewswire.com:443/news-releases/bioarctic-develops-new-treatment-for-gauchers-disease-301671247.html

Related News
» Mountain West Financial, Inc. Ranked as One of the Nation’s Best Military Lenders » Cato Networks Reaches $100 Million ARR in Just Five Years to Become Fastest Growing Enterprise Network Security Startup